Hyde Park, MA

Clinical Trials of New England

Migraine with Aura

Migraine Disorders

Atogepant

Propranolol

Topiramate

Mayo Clinic

condition

allSponsorName

AbbVie

University of Iowa

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This goal of this study is to compare three medications used for migraine preventive treatment.

This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerable than the others.

Research participants will:

* Be randomly assigned to one of the three medications.
* Provide information about their migraine pattern using a daily headache diary and during research visits.

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Clinical Trials of New England | Hyde Park, MA

Site insights

Work at this site?

Active trials

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Trial sponsors